Relevance. This article analyzes the process of treating patients with CHF and CHF with a low ejection fraction against the background of type 2 diabetes mellitus. Heart failure with reduced ejection fraction (HFrEF) remains one of the most significant medical and social problems, particularly when combined with type 2 diabetes mellitus (T2DM). In 2016, the original angiotensin receptor–neprilysin inhibitor (ARNI), sacubitril/valsartan, was introduced under the trade name Yuperio and demonstrated a convincing reduction in hospitalizations and mortality among this patient population. Subsequently, a generic version — Savesto — became available, containing the same combination of neprilysin inhibitor and angiotensin II receptor blocker. The purpose of this study was to evaluate whether Savesto (szcubitril/valsartan) is non-inferior in terms of efficacy and safety in patients with HFrEF and T2DM, including those who were switched from the branded medication. Materials and methods. A total of 57 patients hospitalized with chronic heart failure and acute decompensation on the background of T2DM were enrolled. Treatment with Savesto resulted in clinical improvement, reduction in NYHA functional class, decrease in NT-proBNP levels, favorable dynamics of laboratory parameters, and positive echocardiographic changes. Although some patients experienced symptomatic arterial hypotension and a decline in eGFR, overall tolerability was acceptable, and the safety profile was comparable to that of Entresto. In conclusion, the obtained results indicate that the use of Savesto can be considered as a rational and affordable alternative to the original drug in patients with heart failure with reduced ejection fraction and type 2 diabetes mellitus, while maintaining proven therapeutic value and safety.
| Mualliflar | Файзуллаев Бахром Рустамович, Исломов Иномжон Исломович, Хусаинов Адхам Шухратович, Норматова Умида Юлдашевна |
|---|---|
| Jurnal | Марказий Осиё эндокринологик журнали |
| Nashr sanasi | 2026-06-27 |
| Jild | 6 |
| Son | 2 |
| Til | Rus |
сердечная недостаточность, острая декомпенсация сердечной недостаточности, сакубитрил/валсартан (Савесто), сахарный диабет 2-типа, хроническая почечная недостаточность, низкая фракция выброса, heart failure, CHF, acute decompensation of heart failure, sacubitril/valsartan (Savesto), type 2 diabetes mellitus, chronic renal failure, low ejection fraction, yurak etishmovchiligi, yurak etishmovchiligining o'tkir dekompensatsiyasi, sakubitril/valsartan (Savesto), 2-toifa diabet, surunkali buyrak etishmovchiligi, past otish fraktsiyasi
Relevance:Hyperprolactinemia and prolactin-secreting pituitary adenomas are among the leading endocrine causes of impaired reproductive function in women. Dopamine agonists, such as bromocriptine and cabergoline, are…
Iodine deficiency contributes to the development of various pathological processes in the thyroid gland, such as diffuse goiter, autoimmune diseases, nodules, and thyroid cancer. Approximately one-third of the…
Relevance: Endocrinopathies such as type 2 diabetes and obesity are closely linked to eating behavior patterns. Disordered appetite regulation (emotional, external, and restrictive eating) significantly hinders the…
Riedel’s thyroiditis is one of the most enigmatic forms of inflammatory disorders of the thyroid gland. It is an extremely rare condition characterized by the replacement of normal thyroid parenchyma with dense fibrous…
Relevance: Gestational diabetes mellitus (GDM) is a well-established risk factor for preeclampsia. However, the predictive value of insulin resistance and subclinical inflammation markers in women with established GDM…
Актуальность. Синдром поликистозных яичников (СПКЯ) является одним из наиболее распространённых эндокринных расстройств у женщин репродуктивного возраста и характеризуется выраженной клинико-метаболической…
Thyroid nodules have received attention due to changes in population surveillance systems and growing concerns about the associated financial burden on health care systems, payers, and patients. In this review, we found…
The thyroid gland and liver are intricately interrelated under both physiological and pathological conditions. Liver pathology in thyrotoxicosis is quite common (15–79%) and manifests as increased serum activity of…
Autoimmune thyroiditis (AIT) is one of the most common autoimmune diseases of the thyroid gland and develops as a result of a complex interplay between genetic, environmental, and epigenetic factors. In recent years…
Relevance. Obesity-associated type 2 diabetes mellitus (T2DM) remains a major global health problem. Conventional medical therapy often fails to achieve sustained glycemic control. Therefore, metabolic surgery…